|1.||Minh Nguyen, Khoi: 1 article (04/2015)|
|2.||Le, Xoan Thi: 1 article (04/2015)|
|3.||Fujiwara, Hironori: 1 article (04/2015)|
|4.||Van Nguyen, Tai: 1 article (04/2015)|
|5.||Tanaka, Ken: 1 article (04/2015)|
|6.||Matsumoto, Kinzo: 1 article (04/2015)|
|7.||Nguyet Pham, Hang Thi: 1 article (04/2015)|
|8.||Yue, Rongcai: 1 article (01/2013)|
|9.||Shan, Lei: 1 article (01/2013)|
|10.||Wang, Rui: 1 article (01/2013)|
04/22/2015 - "Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism."
01/01/2013 - "Bacopaside I (10 and 30 mg/kg) treatment produced significant reduction in neurological deficits at 22 and 70 h, and significantly reduced cerebral infarct volume and edema at 70 h, when compared with the ischemia group. "
01/01/2013 - "The present study investigated the effects and possible mechanisms of bacopaside I in a rat model of transient focal ischemia induced by middle cerebral artery occlusion (MCAO). "
01/01/2013 - "Adult male Sprague-Dawley rats were divided into five groups: sham-operated group, ischemia group, and three bacopaside I-treated groups (3, 10 and 30 mg/kg) respectively. "
01/01/2013 - "Bacopaside I (3, 10 and 30 mg/kg) treatment also improved antioxidant enzyme activities including brain superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), in varying degrees, compared with the ischemia group. "
|2.||Brain Ischemia (Cerebral Ischemia)
04/22/2015 - "These results suggest that BM was beneficial for the prevention of cognitive deficits related to cerebral ischemia and also that bacopaside I, via PKC and PI3K/Akt mechanisms, played a role in the neuroprotective effects of BM observed in the mouse model."
01/01/2013 - "These findings indicated that bacopaside I possess a neuroprotective effect against injury caused by cerebral ischemia. "
|4.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
|4.||salicylhydroxamic acid (SHAM)